Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage.
The firm manages over €2 billion of assets dedicated to life science investing and actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to
positively impact its collective future. It invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations with a focus on Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. They sit on the boards of their portfolio companies and play an active role from the formation phase alongside entrepreneurs.
It was headquartered in Paris, Ile-de-France in 1972.
Website:www.sofinnovapartners.com
Industries:
Biotechnology
Life Science
Emergency Medicine
Health Care
Medical Device
AgTech
Medical
Pharmaceutical
Chemical
Commercial
Food and Beverage
Manufacturing
Biopharma
Therapeutics
Industrial Automation
Internet of Things
Software
Investor Types:
Venture Capital
Investment Stages:
Seed
Late Stage Venture
Early Stage Venture
Location:
France
Contact information: